Individual Patient Compassionate Use of Crenolanib

NCT03620318 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

FLT3-ITD Mutation
FLT3/TKD Mutation
PDGFR-Alpha D842V
PDGFRA Gene Amplification

Interventions

DRUG: Crenolanib besylate

Sponsor

Arog Pharmaceuticals, Inc.